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ABSTRACT
DNA mimic proteins have evolved to control
DNA-binding proteins by competing with the
target DNA for binding to the protein. The Ocr
protein of bacteriophage T7 is the most studied
DNA mimic and functions to block the DNA-
binding groove of Type I DNA restriction/modifica-
tion enzymes. This binding prevents the enzyme
from cleaving invading phage DNA. Each 116
amino acid monomer of the Ocr dimer has an
unusual amino acid composition with 34 negatively
charged side chains but only 6 positively charged
side chains. Extensive mutagenesis of the charges
of Ocr revealed a regression of Ocr activity from
wild-type activity to partial activity then to variants
inactive in antirestriction but deleterious for cell via-
bility and lastly to totally inactive variants with no
deleterious effect on cell viability. Throughout the
mutagenesis the Ocr mutant proteins retained their
folding. Our results show that the extreme bias in
charged amino acids is not necessary for anti-
restriction activity but that less charged variants
can affect cell viability by leading to restriction pro-
ficient but modification deficient cell phenotypes.
INTRODUCTION
DNA mimic proteins have evolved to control DNA-
binding proteins by competing with the DNA for
binding. Their mimicry of the structure and electrostatics
of DNA means they can slot into the nucleic acid binding
groove on their target protein and turn the DNA-binding
protein ‘off’ (1–3). The two most striking examples of
DNA mimics are Ocr from the lytic bacteriophage T7
(4) and ArdA (5) from conjugative plasmids and trans-
posons that mediate horizontal gene transfer. Both of
these proteins enhance the propagation of the phage or
mobile elements by overcoming the host restriction/modi-
ﬁcation (RM) system which would normally destroy the
invading DNA (6,7).
The ﬁrst protein to be produced during infection of
Escherichia coli by bacteriophage T7 is overcome classi-
cal restriction (Ocr), the product of gene 0.3 (8,9). The Ocr
protein is the best characterized example of an anti-RM
protein and of a structural mimic of DNA (10–20). Ocr is
a highly negatively charged protein with a similar shape to
that of a bent, double-stranded B-form DNA molecule
24 base pairs in length.
This molecular mimicry accounts for the ability of Ocr
to inhibit, virtually irreversibly (4,9,13) archetypal
versions of all Type I RM enzymes found in many
diverse eubacteria (21). Ocr binds to and completely
occupies the DNA-binding site on the enzyme thereby in-
hibiting the restriction endonuclease activity and protect-
ing the phage genome as it enters the bacterium. Thus, Ocr
greatly assists the spread of phage infection in the bacter-
ial population. The fact that Ocr mimics the general shape
and charge of the DNA segment bound by the RM
enzyme, rather than any speciﬁc base pair sequence,
means that the protein can act against all Type I RM
enzymes, each of which recognizes a different deﬁned
base pair sequence. The Type I RM enzymes (2,22–25)
are complex oligomeric multifunctional enzymes
comprising an S subunit for DNA sequence recognition,
two M subunits for DNA methyltransferase (MTase)
activity and two R subunits for ATP-hydrolysis-
dependent DNA translocation and restriction
*To whom correspondence should be addressed. Tel: +44 131 650 4753; Fax: +44 131 650 6453; Email: david.dryden@ed.ac.uk
The authors wish it to be known that, in their opinion, the ﬁrst three authors should be regarded as joint First Authors.
Published online 7 June 2012 Nucleic Acids Research, 2012, Vol. 40, No. 16 8129–8143
doi:10.1093/nar/gks516
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
endonuclease activities. The M2S1 complex can function as
a sequence-speciﬁc MTase and the R2M2S1 complex can
switch between MTase and restriction endonuclease
activities. The structure of complete Type I RM enzymes
has recently been determined (26). The restriction endo-
nuclease only operates on DNA containing unmethylated
recognition sequences typically found in invading foreign
phage DNA. The structure of the MTase core, referred to
as M.EcoKI, has been determined for the archetypal
EcoKI Type I RM system from E. coli K12 (27). The
target sequence recognized by EcoKI is AACNNNNNN
GTGC with methylation occurring on the adenines at the
underlined positions. The bipartite nature of the target
sequence is characteristic of the Type I RM enzymes.
The S subunit contains two target recognition domains
(TRDs) each responsible for recognizing one part of the
bipartite target sequence.
The structure of Ocr is an elongated, curved dimer.
Each 116 amino acid monomer is decorated with 34
surface-exposed Asp and Glu residues but only 2 Lys
and 4 Arg residues (4,10). Many of the negatively
charged residues of Ocr can be superimposed upon the
equivalent phosphate groups on the DNA molecule
recognized by the RM enzyme (1,4). In addition to
mimicking the charge distribution, Ocr mimics the bend
of 46 in the DNA helical axis induced in DNA when it
binds to the RM enzyme (4). The introduction of the bend
in the DNA by the RM enzyme is energetically costly.
This cost is ‘saved’ when the RM enzyme binds to Ocr
because Ocr is already ‘pre-bent’ (28). By combining elec-
trostatic mimicry of DNA and mimicry of the bent shape,
binding of the RM enzyme to Ocr is energetically more
favourable than binding to DNA. Thus, the overall
binding afﬁnity of the MTase core of the RM enzyme
for Ocr is KA of 2 1010M1, which is 50-fold greater
than the afﬁnity for DNA (13,18–20).
Mutational and chemical modiﬁcation studies of Ocr
revealed the robustness of the DNA mimicry activity.
A large number of single or double mutations in the Ocr
monomer produced no observable effect in vivo or in vitro
(17). Only deletion of the C terminus of Ocr with concomi-
tant structural destabilization (10,14) or disruption of the
dimer interface (19) led to a loss of activity. Chemical
modiﬁcation to remove the negative charges indicated
that 16 Asp or Glu side chains per Ocr monomer
needed to be neutralized before the binding afﬁnity of
Ocr for M.EcoKI fell to approximately the same level as
the DNA-M.EcoKI afﬁnity (16). Further chemical modi-
ﬁcations were required to completely inactivate the DNA
mimicry. Importantly, the extensive chemical modiﬁcation
of over 15% of the amino acid sequence had no deleteri-
ous effect on the fold of the Ocr protein.
In the current work, we have mutated groups of ﬁve or
six Asp or Glu located together in the primary structure of
Ocr and then combined these groups to produce Ocr mol-
ecules containing up to 17 mutations per monomer. The
effect of these mutations on the ability of Ocr to act as an
anti-RM DNA mimic against the archetypal EcoKI Type
I RM system was examined. We found that 12 Asp and
Glu located in the central portion of the Ocr dimer were
important for DNA mimicry. The clustering of these
amino acids and the decrease in abundance of positively
charged amino acids would be the minimal evolutionary
requirements for the formation of the DNA mimic.
However, the evolutionary path to the Ocr protein
appears to have to surmount a barrier. The Ocr variants
can be grouped into classes: fully active, inactive but
showing some toxicity for cell viability and inactive with
no deleterious effect on cell viability. Our data seem to
indicate an evolutionary progression from an inactive pre-
cursor protein via a toxic protein to the fully active
anti-RM protein which has lost the toxicity.
MATERIALS AND METHODS
Chemicals, bacterial strains and phage
All chemicals were purchased from Sigma-Aldrich un-
less otherwise stated. Escherichia coli XL1 Blue
supercompetent cells were obtained from Stratagene (La
Jolla, CA) and E. coli BL21(DE3) was from Invitrogen
Life Technologies (Carlsbad, CA). Escherichia coli
NM1261 (rm; no RM system) and E. coli NM1049
(r+m+; EcoKI Type IA RM system) were a kind gift of
Professor Noreen Murray (School of Biology, University
of Edinburgh, UK) (29). These two NM strains were con-
verted to DE lysogens as described by McMahon et al. (5).
Escherichia coli NM1041 (E. coli MG1655 r+m+; EcoKI
Type IA RM, system clpX ::kan) (29) and E. coli NM1057
(E. coli MG1655 rm+; no RM system, DhsdREcoKI, clpX
::kan) were kind gifts from Dr Angela Dawson (School of
Physics and Astronomy, University of Edinburgh).
Virulent unmodiﬁed bacteriophage lambda lv.o, or
modiﬁed lambda lv.k were provided by Professor
Noreen Murray.
Plasmids
Plasmid pAR2993, based upon the vector pET1, harbours
the gene encoding wild-type Ocr located just downstream
of an isopropyl b-D-1-thiogalactopyranoside (IPTG) indu-
cible T7 promoter (14). Plasmids pAR2993 and pAR3786
and pAR3790 encoding truncated forms (deletions of the
C-terminal 7 or 17 amino acid residues, termed Ocr109
and Ocr99, respectively) of wild-type Ocr were a kind
gift from Dr Alan Rosenberg and Professor William
Studier (Brookhaven National Laboratory, USA).
Plasmids pOcrD12N/D26N, pOcrD25C and pOcrD73C
were derivatives of pAR2993 encoding genes to produce
Ocr containing a double substitution D12N/D26N or
single substitutions D25C and D73C (13,17). Plasmid
pET24a was purchased from Novagen (Madison, WI).
pBRsk1 is an engineered version of pBR322 (4361 bp) in
which one of the two EcoKI sites (4024–4036) has
been removed by site-directed mutagenesis (30). The
unmethylated form of pBRsk1 used in the nuclease
assays was prepared from E. coli NM1261 (rm). The
plasmid pTrc99A (31) was a gift from Dr Angela Dawson.
Generation of mutants of Ocr
Standard DNA manipulation procedures were used
throughout (32). All constructs were sequenced to ensure
8130 Nucleic Acids Research, 2012, Vol. 40, No. 16
no errors had been introduced during ampliﬁcation. For
clarity, references to the amino acid sequence of the Ocr
correspond to the numbering system for the mature
full-length protein that lacks the N-terminal methionine,
which is subject to post-translational cleavage. We
generated a series of Ocr mutants, each containing
multiple (between 5 and 17) amino acid substitutions
that targeted acidic residues on the surface of the
protein. The majority of mutations were generated using
the QuikChange II Site-Directed Mutagenesis kit from
Stratagene (La Jolla, CA) and plasmid pAR2993 and de-
rivatives. The primer pairs for the polymerase chain
reaction (PCR) along with the corresponding DNA
template used to generate each set of mutations are
given in Supplementary Table S1. The PCR comprised
an initial denaturation step of 95C for 30 s followed by
18 cycles of denaturation at 95C for 30 s, annealing at
55C for 1min and elongation at 68C for 6min 30 s.
The PCR mix (total volume 50 ml) included PfuUltra HF
DNA polymerase (2.5U), 10mM Tris-HCl (pH 9.0 at
room temperature), 50mM KCl, 1.5mM MgCl2, 200 mM
of each deoxynucleoside triphosphate, 40 pM of each
primer and 5 ng of template DNA. DpnI (10U) was
then added directly to the ampliﬁcation reaction and
incubated at 37C for 60min to remove the original
template. After transformation of E. coli XL1-Blue
supercompetent cells, recombinant clones were selected
by growth on LB-agar plates containing 100 mg/ml car-
benicillin. Plasmid DNA was prepared from individual
colonies and sequenced to verify whether the anticipated
mutations had been introduced.
The strategy adopted for the creation of pOcr/POcr
involved using PCR to amplify and fuse together two dif-
ferent fragments of DNA encoding Ocr (using pAR2993)
and a synthetic version of the gene encoding Ocr, known
as POcr (plasmid pPOcr created by GeneArt, Regensberg,
Germany), in which all the acidic acid residues had been
mutated (Asp and Glu to Asn and Gln, respectively). Two
PCRs (PCR1 and PCR2) were conducted separately using
the following primer pairs: primer A 50-AGCTCATATG
GCTATGTCTAACATGACTTACAACAACGTTTTC
GAC-30 with primer B 50-CTGCAGAATACGGATTAC
GTTCTTGGTGTCAGGCATCAGACC-30 and primer
C 50-GGTCTGATGCCTGACACCAAGAACGTAAT
CCGTATTCTGCAG-30 with primer D 50-GAATTCA
AGCTTTTACTGTTGGTTCTGCTGATATTGCTG-30
to amplify speciﬁc sections from pAR2993 and pPOcr,
respectively. The PCR cycle parameters comprised an
initial denaturation step of 95C for 30 s followed by 25
cycles of denaturation at 95C for 30 s, annealing at 55C
for 1min and elongation at 72C for 1min. The compos-
ition of the reaction mixture was the same as described
earlier. Both PCRs generated ampliﬁed products of the
anticipated size, which were gel puriﬁed and then used
as template for a third PCR using primers A and D
(PCR3). Note that primers B and C of PCR1 and PCR2
were designed to generate a partial overlap, which
facilitated the generation of full length template during
the ﬁrst extension cycle of PCR3. This full length
product then allowed ampliﬁcation of Ocr/POcr using
primers A and D. The ampliﬁed product was then
digested with NdeI and HindIII and ligated into the cor-
responding sites of pET24a. The ligation mix was used to
transform E. coli XL1-Blue supercompetent cells and re-
combinant clones were then selected by growth on
LB-agar plates supplemented with 50 mg/ml kanamycin.
Plasmid DNA was prepared from individual colonies
and sequenced to verify whether the anticipated mutations
had been introduced.
For the purposes of performing the in vivo restriction
alleviation (RA) assay described below, the gene encoding
wild-type Ocr or mutant Ocr had to be transferred to an
expression system not based upon the T7 promoter. Each
plasmid was ampliﬁed by PCR using primers that included
an NdeI restriction recognition site (CATATG), which
overlapped the ATG start codon of the gene, and a
HindIII site immediately 30 of the stop codon. The PCR
products were then ligated into the corresponding NdeI/
HindIII sites of pTrc99a. The resulting plasmids were
sequenced to ensure no mistakes had been introduced
during the ampliﬁcation.
In vivo phage restriction assay
The activity of the mutated forms of Ocr was assessed
using an in vivo restriction assay with virulent unmodiﬁed
bacteriophage lambda lv.o or EcoKI-modiﬁed lambda lv.k
as described previously (33). The efﬁciency of plating of
the phage was determined on E. coli NM1261 (DE3)
(rm) transformed with plasmids expressing Ocr or its
mutants compared to E. coli NM1049 (DE3) (r+m+) trans-
formed with the same plasmids. Cells containing a
non-functional Ocr would not be able to inhibit EcoKI
and phage propagation would be restricted whereas
those containing a functional Ocr would be able to
inhibit EcoKI and phage propagation would not be re-
stricted. No IPTG was present in the BBL agar because
the promoter is sufﬁciently leaky to produce sufﬁcient Ocr
protein (4).
In vivo phage modiﬁcation assay
The activity of the mutated forms of Ocr was assessed
using an in vivo modiﬁcation assay. Virulent unmodiﬁed
bacteriophage lambda lv.o was plated on a r
m+ strain
(E. coli NM1057) after the strain had been transformed
with a vector control or the Ocr mutant overexpression
plasmids (33). IPTG (50mg/ml) was included in the BBL
agar. Plaques found after overnight incubation were
expected to be modiﬁed if Ocr activity was compromised.
If Ocr activity was functional, then the phage would not
be modiﬁed. The recovered phage were assessed for modi-
ﬁcation using the in vivo restriction assay comparing efﬁ-
ciency of plating on E. coli NM1041 (r+m+, clpX
) versus
E. coli NM1057(rm+, clpX
).
In vivo restriction alleviation assay
The RA assay exploits the ClpXP protease found in E. coli
K12 cells and the observation that the addition of the
adenine analogue and mutagen, 2-aminopurine (2AP),
leads to the production of unmethylated targets for
EcoKI on the chromosome. ClpXP, which cleaves the
HsdR subunit of EcoKI, is absent in the strain E. coli
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NM1041(r+m+). In the absence of ClpXP but presence of
2AP, the EcoKI enzyme cleaves the chromosome and the
cell dies. However, if an active Ocr protein is also present,
the EcoKI is inactivated and the cell survives even when
growing on a 2AP medium without ClpXP. Therefore, the
anti-restriction activity of Ocr can be measured by
determining cell survival, as previously described by
Makovets et al. (34).
The RA activity was assayed with 100 ml cultures of
E. coli NM1041 (r+m+) transformed with plasmids ex-
pressing each of the Ocr mutants. Cultures were diluted
using a solution of L Broth and glycerol (5:2 ratio) to
provide equal starting cell concentrations. Each of the
cultures were diluted in 10-fold increments from 101 to
108 and spotted in triplicate onto LB-agar plates contain-
ing different concentrations of 2AP: 0, 5, 10, 20 or
40 mg/ml. The plates were supplemented with kanamycin
(30mg/ml), ampicillin (50 mg/ml) and IPTG (50mg/ml). In
addition, as a control and to determine the total cell con-
centration, the cultures were plated onto a plate supple-
mented only with kanamycin (30 mg/ml) and ampicillin
(50mg/ml). The plates were inverted and sealed in an
air-tight container and incubated at 37C for 18 h after
which colony numbers were counted and the number of
viable cells per ml calculated.
Bacterial growth curves
Cultures of the E. coliNM1041 (r+m+, clpX
) transformed
with each of the plasmids expressing Ocr or its mutants
were incubated at 37C. About 250 ml samples were taken
from each culture and used to inoculate two lots of 5ml L
Broth, one with and one without IPTG (50 mg/ml). These
were incubated for 15min to obtain a similar population
density for each culture. All of the cultures were in the lag
phase. Sterile covered microplates (96-well plates) and lids
were obtained from Greiner. About 200 ml samples from
the prepared cultures were pipetted, in triplicate, with and
without 50 mg/ml IPTG, into the 96-well plates. Bacterial
growth curves were obtained by measuring the optical
density of the cultures as a function of time. The optical
density measurements were carried out by a Fluorostar
OPTIMA plate reader (BMG Labtech). The reader was
programmed to measure the samples on the plate every
15min for 10 h at a wavelength of 600 nm. The reader
maintained a temperature of 37C throughout the experi-
ment and a medium shaking speed of 200 rpm between
readings.
Cell growth on solid media in the presence of Ocr variants
Determining the loss of viability for E. coli NM1041
(r+m+, ClpX) and E. coli NM1057 (rm+, HsdR
,
ClpX) transformed with various plasmids expressing
Ocr or its mutants was performed as follows. Cultures
of the bacterial strains were grown after transformation
with the plasmid expressing Ocr or its mutants. The cells
were grown in L Broth with aeration at 37C, shaking at
200 rpm for 18 h. Serial dilutions of the cultures were
spotted onto LB-agar plates, supplemented with
Kanamycin (30 mg/ml), Ampicillin (50 mg/ml) and IPTG
(50mg/ml). The plates were incubated for 18 h at 37C.
Viable counts for each strain transformed with each
mutant were determined. Controls were cells transformed
with either the plasmid expressing wild-type Ocr protein
or the pTrc99A expression vector.
Microscopy
Overnight cultures of E. coli NM1041 (r+m+, ClpX
) cells,
transformed with wild-type Ocr or the mutant derivatives,
were used to inoculate 10ml of L Broth (50ml). The
cultures were grown to an optical density of 0.2 at
600 nm and subsequently induced with IPTG (50 mg/ml)
and incubated for a further 2.5 h (the OD600 was
measured to ensure each culture was still in the logarith-
mic phase of growth). To condense the nucleoid, chloram-
phenicol (10 ml) was added to each culture and incubation
at 37C continued for 30min. The bacterial cells were
ﬁxed with the addition of methanol at a 2:1 ratio and a
further incubation on ice for 10min. The cells were col-
lected by centrifugation and resuspended in buffer; 10mM
Tris–HCl (pH 7.5) 10mM MgSO4. Prior to microscopy
analysis, the cells were stained with 40,6-diamidino-2-
phenylindole (DAPI) (0.5 ml, 5mg/ml) and observed
under a ﬂuorescence microscope.
Protein production and puriﬁcation
Escherichia coli BL21(DE3) was transformed with each of
the recombinant plasmids encoding the mutated forms of
Ocr. Cells were grown at 37C in two 2 -l conical ﬂasks,
each containing 1 l L Broth supplemented with the appro-
priate antibiotic for selection (Kanamycin 30 mg/ml or
Ampicillin 50 mg/ml) to an optical density at 600 nM of
0.5. Heterologous gene expression was then induced by
adding IPTG to a ﬁnal concentration of 1mM and growth
was then continued for a further 2.5 h before harvesting
the cells by centrifugation (8000g, 15min, 4C). Analysis
of the cell-free extracts by sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) and
Coomassie-blue staining showed that most of the
mutated forms of Ocr were overexpressed at comparable
levels to that observed for wild-type protein. Furthermore,
all the overexpressed proteins were produced in a soluble
form and could be puriﬁed to homogeneity using the
protocol described previously (17). M.EcoKI and EcoKI
were prepared as previously described (35,36). All Ocr
protein concentrations refer to the dimeric form of Ocr
or its derivatives.
Glutaraldehyde crosslinking
Chemical crosslinking was used to assess whether each of
the Ocr mutant proteins exist as a homodimer in solution.
A 60 mg aliquot of each protein was diluted with 10ml of
20mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer (pH 7.5) i.e. ﬁnal protein concentra-
tion of 430 nM. Glutaraldehyde (25% w/v) was added to
the solution to give a ﬁnal concentration of 1% (w/v). The
mixture was incubated at room temperature for 2min and
then the reaction was quenched by adding 0.25ml of
freshly prepared 2M sodium borohydride in 0.1M
NaOH. After incubating for a further 20min at room
temperature, a 10 ml aliquot of a 10% (w/v) sodium
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deoxycholate solution was added. The protein was then
precipitated by addition of trichloroacetic acid (TCA) and
pelleted by centrifugation. Each pellet was dissolved in a
small volume of SDS-PAGE loading buffer. A small
amount of 1M Tris HCl pH 8.0 was added to the
samples to neutralize the acid. Samples were then
analysed by SDS-PAGE on a 4–12% polyacrylamide
gradient gel. Each sample was run alongside non-treated
protein for comparison. A wild-type Ocr sample was used
as a positive control.
Circular dichroism for assessment of Ocr folding
Far UV (190–260 nm) circular dichroism (CD) analysis
was performed on a Jasco model J-180 spectropolorimeter
(Jasco Corp., Tokyo, Japan) at 25C in 10mM Tris HCl
pH 8.0, 50mM NaF, 7mM mercaptoethanol buffer at a
protein concentration of 30 mM using a 0.2mm pathlength
cell. Spectra were corrected for buffer contribution. Each
spectrum was an accumulation of four individual scans.
Isothermal titration calorimetry for assessment of binding
of Ocr to M.EcoKI MTase
All isothermal titration calorimetry (ITC) experiments
were conducted using a VP-ITC instrument (Microcal,
Northampton, MA). Protein samples were exchanged
into 20mM Tris–HCl pH 8.0, 6mM MgCl2, 7mM
2-mercaptoethanol using a PD-10 column (GE
Healthcare, Piscataway, NJ) for each experiment. The
protein concentration was adjusted and then S-adenosyl-
L-methionine (SAM, New England Biolabs) added to a
ﬁnal concentration of 100 mM. All solutions were thor-
oughly degassed prior to use. Typically, Ocr at a concen-
tration of 30 mM was titrated into M.EcoKI at a
concentration of 3 mM (1.4ml active volume). All titra-
tions were performed at 25C. The data were then ﬁtted
to a single-site binding model using the Microcal LLC
Origin software package.
In vitro DNA cleavage assay for assessment of inhibition
of the endonuclease activity of EcoKI
The in vitro endonuclease assay monitored the lineari-
zation of unmethylated plasmid pBRsk1 by EcoKI RM
enzyme in the presence or absence of Ocr or its variants.
Typically, the reaction was performed in a 50 ml reaction
volume containing 10mM Mg acetate, 10mM
Tris-acetate, 7mM 2-mercaptoethanol, 50 mg/ml BSA,
2mM ATP, 0.1mM SAM, 3 nM pBRsk1 and initiated
by adding EcoKI to 30 nM. Where required, each Ocr
protein was preincubated with the EcoKI at a molar
ratio of 10:1 or 20:1 (Ocr:EcoKI), for 2min at room tem-
perature prior to adding to the other reaction components.
Digests were performed for 8min at 37C before stopping
by incubation at 68C for 10min. The extent of reaction
was then analysed by agarose gel electrophoresis on a
0.8% 1 TAE gel. DNA bands were visualized under
UV illumination after staining with ethidium bromide.
Structure visualization
PDB ﬁles (Ocr: 1S7Z and M.EcoKI: 2Y7C (with Ocr
bound) 2Y7H (with DNA bound)) were viewed using
UCSF Chimera (37).
RESULTS
Location of mutations on the atomic structure of Ocr
Mutant forms of Ocr containing multiple amino acid sub-
stitutions (5–17 per monomer) were generated to help
deﬁne speciﬁc structural features of the molecule that
are key to its interaction with the Type I RM system.
The atomic structure of Ocr facilitated the rational
design of a series of mutant forms of the molecule in
which patches of negative charge were systematically
removed from the protein surface. Speciﬁcally, a number
of acidic residues were conservatively mutated to neutral
amino acids (i.e. Asp to Asn and Glu to Gln). However,
for convenience, some existing mutated forms of Ocr (14)
were employed as templates for the mutagenic PCR. In
such instances (i.e. Mut2, Mut3, Mut7, Mut10 and
Mut11), one of the acidic residues was substituted with
Cys. Our strategy was to generate a succession of clustered
mutations to target deﬁned structural features of the Ocr
protein, such as exposed loops or helices, which together
covered the entire surface of the protein. The multiple
mutations of Ocr are shown in Table 1 and their locations
on the Ocr structure in Figure 1.
In vivo restriction assay
The activity of each mutated form of Ocr was assessed
in vivo using a restriction assay. Infection with unmodiﬁed
virulent l phage (lv.o) of two different E. coli strains,
transformed with pET24a or the plasmids expressing
Ocr or its variants, was carried out. Escherichia coli
NM1049(DE3) contains the EcoKI Type IA RM system
(r+m+) while E. coli NM1261(DE3) lacks the RM system
(rm). As anticipated, the efﬁciency of plating (eop) of
Table 1. The Ocr variants examined in this work
Mutant name Changes to wild-type amino acid sequence
Mut1 D12N, E16Q, E20Q, D25N, D26N
Mut2 D25C, D26N, D29N, D31N, D32N, D35N
Mut3 E59Q, D62N, E64Q, E66Q, D67N, D73C
Mut4 D92N, E95Q, D96N, E98Q, D99N
Mut12 E59Q, D62N, E64Q, E66Q, D67N
Mut7 Mut2+Mut4
Mut10 Mut2+Mut4+Mut12
Mut11 Mut2+Mut12
Mut13 Mut4+Mut12
Mut16 Mut1+Mut12
Ocr99 Deletion of C-terminal amino acids 99–116
Ocr109 Deletion of C-terminal amino acids 109–116
Ocr/POcr D76N, E87Q, D92N, E95Q, D96N, E98Q, D99N,
E103Q, E106Q, E107Q, E109Q, E110Q, E112Q,
E113Q, D114N, E115Q, E116Q
POcr All 34 Asp and Glu changed to Asn and Gln,
respectively.
The Ocr99 and Ocr109 variants have been described previously (14).
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lv.o on E. coli NM1049(DE3) containing pET24a was four
orders of magnitude lower than the eop on E. coli
NM1261(DE3) with the vector (Table 2). The methylated
form of l (lv.k) showed an eop of 1 as expected (data not
shown). Comparing the two strains when transformed
with the plasmid expressing the wild-type Ocr gave essen-
tially identical numbers of plaques and an eop of 1.45,
demonstrating that Ocr had inhibited the Type I RM
system. Assaying the mutated forms of Ocr in the same
way showed that most of the mutants were fully active
with an eop ranging from 0.54 to 1.5. Cells expressing
Mut10, Mut11 or Mut13 showed low eop similar to cells
containing the vector alone. These results suggest that
Mut10, Mut11 and Mut13 have no signiﬁcant anti-
restriction activity in vivo. The synthetic gene encoding
POcr in which all 34 Asp or Glu residues in Ocr were
substituted by Asn and Gln was also inactive in this
assay (data not shown) and was not investigated further.
In vivo phage modiﬁcation assay
To assess the methylation activity of each of the mutants,
a phage modiﬁcation assay was carried out. Unmethylated
phage, lv.o, was used to infect the modifying host E. coli
NM1057 (rm+, clpX
-) transformed with either a control
vector or with plasmids expressing Ocr or its variants
Figure 1. The location of the Ocr mutants on the dimeric atomic structure (PDB 1S7Z, 4). The residues targeted for mutagenesis are highlighted as
coloured sticks. (A) The locations of mutations for Mut2 (magenta), Mut4 (blue) and Mut12 (red) are shown in left-hand monomer and Mut1
(yellow) and Ocr/POcr (orange) in the right-hand monomer. (B) A view rotated 90 from that in panel (A) showing the bottom of the structure.
Table 2. In vivo restriction and modiﬁcation assays
Ocr variant expressed Efﬁciency of plating of lv.o [Phage
titre on E. coli NM1049(DE3)
(r+m+)]/[Phage titre on E. coli
NM1261(DE3) (rm)]
Efﬁciency of plating of lv.o
[Phage titre on E. coli NM1041
(r+m+, clpX
)]/[Phage titre on
E. coli NM1057(rm+, clpX
)]
Active versus
whole RM
system in vivo
Active versus
M.EcoKI alone
in vivo
pET24a 3.80 104 0.96 N N
Wild type 1.45 <104 Y Y
Mut1 0.94 <104 Y Y
Mut2 0.77 <104 Y Y
Mut3 0.82 0.79 Y N
Mut4 1.33 <104 Y Y
Mut7 1.5 <104 Y Y
Mut10 2.30 104 1 N N
Mut11 1.15 104 1.31 N N
Mut12 1.29 0.16 Y Y/N
Mut13 5.00 104 0.67 N N
Mut16 0.54 0.47 Y N
Ocr/POcr 0.78 1 Y N
Ocr99 0.30a 3.80 104 Y Y
Ocr109 0.32a 0.55 Y N
Note that an efﬁciency of plating of 1 indicates an active Ocr protein in the restriction assay whereas an eop of 0 (i.e. <104) in the modiﬁcation
assay indicates an active Ocr protein. Errors in the number of plaques where ±20% from full plate assays performed in triplicate.
aData from (13,14).
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(IPTG was added 50 mg/ml). This strain lacks the ClpXP
protease and the gene expressing the R subunit of EcoKI.
The strain still expresses the M.EcoKI MTase and, there-
fore, phages recovered from a single plaque should have
been methylated by the action of M.EcoKI unless the Ocr
protein was active. The activity of Ocr was assessed by
determining the eop of the phages recovered from a
single plaque on E. coli NM1057 (rm+, clpX
). The eop
was determined on the restrictive host E. coli NM1041
(r+m+, clpX
) relative to the modifying host E. coli
NM1057 (rm+, clpX
). If the Ocr variant was active
then the titre of recovered phages per ml after plating
lv.o on E. coli NM1057 would be lower than the titre of
phages per ml on E.coli NM1041, and an eop reﬂecting a
fully restrictive condition would be observed.
The results showed that wild-type Ocr and mutants
Mut1, Mut2, Mut4, Mut7 and Ocr99 were active in pre-
venting DNA modiﬁcation by M.EcoKI as their eop was
very low (e.g. Ocr99) or 0 (i.e <104), Table 2. Ocr
mutant Mut12 showed a greatly reduced effectiveness
(eop of 0.16) while the others showed no activity (eop of
0.5–1). Arbitrarily, we deﬁne that an eop of 0.5 or greater
indicates anOcr that is inactive in inhibitingM.EcoKI inE.
coli NM1057. It is noteworthy that some Ocr variants
active against restriction in vivo were not able to prevent
modiﬁcation in vivo (Mut3, Mut12, Mut16 and Ocr/POcr).
Also of note is that addition of one further substitution
(D73C) to change Mut12 into Mut3 converts the Ocr
protein from being able to partially inhibit modiﬁcation
to being unable to inhibit modiﬁcation.
In vivo restriction alleviation assay
For E. coli NM1041 (r+m+, clpX), the mutagen
2-aminopurine is toxic. Toxicity results from cleavage of
the chromosome in the absence of ClpXP control or Ocr
inhbition, so that cell growth is reduced or prevented as
EcoKI destroys the chromosome. The presence of an
active Ocr protein in the cell will then rescue the viability
by blocking the action of EcoKI, a phenomenon known as
RA. Thus colonies will grow on media containing 2AP in
the presence of an active Ocr antirestriction protein.
The effect on the viable cell count for E. coli NM1041
when transformed with plasmid vector alone or with
plasmids encoding the Ocr mutants is shown in Figure 2
as a function of 2AP concentration. In the absence of 2AP
and IPTG, the strain grew equally well when transformed
with various Ocr plasmids or the vector alone (108 cells
per ml). The addition of IPTG caused an unanticipated
reduction in cell viability for three of the mutants, Mut12,
Mut16 and Ocr/POcr even when no 2AP was present
(103 to 104 cells per ml). The addition of 2AP to
5 mg/ml had no further effect on any of the transformed
strains. A 2AP concentration of 10 mg/ml led to a complete
loss of viability for cells expressing Mut3. Concentrations
of greater than 10 mg/ml also killed cells expressing Mut7,
Mut10, Mut11, Mut12, Mut13, Mut16, Ocr/POcr and
those containing only the vector. Those cells expressing
the wild-type Ocr, Mut1, Mut2, Mut4, Ocr99 or Ocr109
were viable even at the highest concentrations of 2AP used
(40 mg/ml).
The results show four distinct phenotypes, namely
active antirestriction giving full protection against all con-
centrations of 2AP (Wild type Ocr, Mut1, Mut2, Mut4,
Ocr99, Ocr109), no antirestriction effect and indistinguish-
able from the vector (Mut7, Mut10, Mut11, Mut13), no
antirestriction coupled with a deleterious effect on cell
growth when induced with IPTG (Mut12, Mut16 and
Ocr/POcr) and lastly no IPTG effect on cell growth but
also no antirestriction and an enhanced sensitivity to 2AP
(Mut3). Again the single amino difference between Mut12
and Mut3 causes a noticeable difference in behaviour.
Bacterial growth
The RA assay revealed that even in the absence of 2AP to
induce RA, cell viability could be compromised by some
Ocr variants (Mut12, Mut16 and Ocr/POcr). To further
explore this phenomenon, growth properties of plasmid-
containing E. coli NM1041 (clpX, r+m+) were examined
without 2AP but with IPTG and selective antibiotics.
Although the growth curves (Figure 3) generally high-
lighted the same deleterious Ocr mutants, Mut3, Mut12,
Mut16 and Ocr/POcr, as the RA assay, there were some
minor differences in growth behaviour between these
mutants. The presence of Ocr or mutants Mut1, Mut2,
Mut4, Mut7, Mut10, Mut11, Mut13, Ocr99 and Ocr109
showed normal exponential growth with a doubling time
of 130min after a lag time of 150min whether ITPG
was present or not. Mut3 which produced a strong effect
in the RA assay allowed normal growth in the absence of
IPTG and slow growth with a doubling time of 150min
in the presence of IPTG. The presence of Mut12 in the
absence of ITPG caused a long lag time of over 300min
before exponential growth started with a doubling time of
150min. The addition of ITPG stopped growth
Figure 2. The RA assay measuring cell survival of E. coli NM1041
(clpX, r+m+) when transformed with various plasmids expressing
Ocr or its mutant forms. The graph shows growth on LB-agar plates
supplemented with antibiotics (cyan) only, antibiotics and ITPG (green)
and, in the presence of antibiotics, IPTG plus increasing concentrations
of 2AP (5, 10, 20 and 40 mg/ml are red, magenta, blue and olive,
respectively).
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altogether. The presence of Mut16 strongly slowed growth
in the presence or absence of IPTG as suggested by the
RA assay. The cells started to grow exponentially but then
halted growth at a low optical density. Ocr/POcr, which
also reduced cell viability in the RA assay, allowed normal
growth in the absence of IPTG and limited growth with a
doubling time of 200min and halting at a low optical
density in the presence of IPTG. Thus Ocr/POcr would
appear to be not as deleterious as Mut12 or Mut16.
Cell growth on solid media in the presence of Ocr variants
The deleterious effect of Mut12, Mut16 and Ocr/POcr on
viability even in the absence of RA induced by 2AP and
the strong effect of Mut3 in the presence of 2AP was
examined on agar plates using the two strains, E. coli
NM1041 (r+m+, clpX) and E. coli NM1057 (rm+, clpX)
(Figure 4). 2AP was not added so the chromosome would
be modiﬁed by EcoKI. Spotting serial dilutions of the
cultures onto the plates showed that cells expressing an
active EcoKI system (E. coli NM1041) and Ocr/POcr,
Mut12 or Mut16 grew poorly. Cells expressing EcoKI
and the Mut3 Ocr mutant were slightly affected
compared to the controls. However, E. coli NM1057
cells also lacking the R subunit of EcoKI, and thus an
active RM system, grew normally or almost normally
(Mut16) in the presence of all the Ocr variants tested.
These results are comparable to the changes in growth
rate measured in liquid culture. The results indicate that
the deleterious effect is speciﬁc to the RM pathway and
suggest that some of the Ocr mutants are creating a situ-
ation where EcoKI is unable to modify the target sites on
the chromosome leading to restriction of the chromosome
(i.e. an r+m+/ phenotype).
Microscopy
Escherichia coli NM1041 cells expressing Ocr or its
variants were induced with IPTG, stained with DAPI
and examined by ﬂuorescence microscopy (Figure 5).
Most cultures contained normal cells with intact nucleoids
similar to those expressing wild-type Ocr or transformed
with the vector alone. Ocr variants Mut3, Mut12, Mut16
and Ocr/Pocr, however, showed extensive ﬁlamentation
indicating induction of the SOS response and inhibition
of cell division. This effect is consistent with DNA damage
caused by endonucleolytic cleavage. These microscopy
data suggest that EcoKI restriction function is active in
the presence of mutants Mut3, Mut12, Mut16 and Ocr/
POcr, but that modiﬁcation is compromised leading to
unmodiﬁed target sites on the chromosome that are then
cleaved.
Protein expression and puriﬁcation
Each mutated version of Ocr gave levels of heterologous
gene expression similar to that of the wild-type protein
except for the synthetic gene expressing the POcr variant
which showed no protein product on SDS-PAGE of cell
extracts. The other mutated recombinant proteins were all
soluble and could be puriﬁed to near homogeneity using
the same protocol as for wild-type Ocr (17). The far UV
CD analysis indicated that the introduction of the various
mutations had no signiﬁcant effect on the secondary struc-
ture of the mutated Ocr proteins, a selection of which are
shown in Figure 6. Spectra were analysed using the
Dichroweb online secondary structure deconvolution
program (38). Analysis using the CDSSTR method gave
an a-helical content of 60% for wild-type Ocr, which is in
good agreement with the crystal structure. Similar values
(±2%) were obtained for the mutant proteins. It was
therefore concluded that all the mutant proteins retained
the overall fold of wild-type Ocr.
The wild-type Ocr protein is known to begin to dissoci-
ate into monomers below 300 nM (14).Glutaraldehyde
crosslinking was used to determine whether dimers
existed for each of the mutant Ocr proteins. It was
found that Ocr and its mutants showed the presence of
dimers (and some higher order species) even at concentra-
tions of 400 nM (Supplementary Figure S1) and thus we
conclude that the extensive mutagenesis of Ocr produces
no changes in its quaternary structure behaviour.
Isothermal titration calorimetry for measurement of
binding of Ocr to M.EcoKI MTase
ITC was used to analyse the interaction between M.EcoKI
and the wild-type or mutated forms of Ocr in vitro. Each
injection peak was integrated and the heat of dilution
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Figure 3. Cell growth with the Ocr mutants expressed in E. coli,
NM1041 (clpX, r+m+) in the absence of 2AP. It is clear that cells
expressing different Ocr mutants grow at different rates. pTrc99A is
the vector alone, all other data are for cells expressing Ocr wild-type
(wt), Ocr99, Ocr109, Ocr/POcr or mutants Mut1 to Mut16. OD600
measurements were recorded every 15min for 500min. Errors are
±7% for triplicate measurements (error bars not shown for clarity).
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subtracted. A plot of the heat of interaction versus the
molar ratio of Ocr dimer to M.EcoKI was then generated.
As found previously (13,17), the interaction between
wild-type Ocr and M.EcoKI was highly exothermic and
exhibited essentially stoichiometric binding (one Ocr
dimer per M.EcoKI) within the concentration range
used in these experiments (Table 3). The binding was
too strong to allow determination of the dissociation
constant which has been estimated as 50pM by other
methods (13). Such tight binding is outside the range ac-
cessible by ITC. Except for Mut10 and Mut11, which
displayed no apparent binding (H=0), Figure 7 and
Figure 4. Loss of cell growth of E. coli NM1041 (clpX, r+m+) and NM1057 (clpX, rm+) expressing the mutants Mut3 (m3), Ocr/POcr, Mut16
(m16) and Mut12 (m12) compared to cells expressing wild-type Ocr (wtOcr) or transformed with vector alone (pTrc99A). Serial dilutions of cultures
were spotted onto LB-Agar plates supplemented with appropriate antibiotics. The dilutions of 102, 103 and 104 fold of the liquid culture are
spotted in triplicate clockwise for E. coli NM1041 and anticlockwise for E. coli NM1057 from the top of the plate.
pTrc99A
wtOcr
Mut12
Ocr/POcr
Mut16
Mut3
Figure 5. Fluorescence microscopy images of cell morphology of bacterial cultures of E. coli NM1041 (clpX, r+m+) transformed with plasmids
expressing wild-type Ocr (wtOcr) or its variants. Control cells were transformed with the vector pTrc99A. Cell nucleoids were revealed with DAPI
staining. Scale bar is 10 microns.
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Table 3, the ITC data showed a highly exothermic inter-
action between the Ocr mutants and M.EcoKI under the
experimental conditions employed. Furthermore, a stoi-
chiometry consistent with one Ocr dimer per M.EcoKI
was evident for all of the Ocr mutants (Table 3).
However, several of the Ocr variants showed sigmoidal
titration curves, Figure 7, indicating binding intermediate
between the tight binding of the wild-type Ocr and the
absence of binding by Mut10 and Mut11. For these sig-
moidal transitions obtained with Mut3, Mut12, Mut13
and Mut16, estimates of the dissociation constant, Kd,
lay in the range of 20–80 nM. This range of Kd indicates
that these mutant proteins bind less well than DNA to
M.EcoKI (Kd 1 nM under these conditions as deter-
mined using a ﬂuorescence anisotropy assay (28,39)).
The Kd for the interaction of Mut10 or Mut11 with
M.EcoKI must be greater than 1 mM. Fluorescence spec-
troscopy measurements using a GFP-tagged version of
M.EcoKI (40) suggest that the Kd for Mut10 binding to
M.EcoKI is 1.5mM (Stephanou,A.S., unpublished data).
In vitro DNA cleavage assay for assessment of inhibition
of the endonuclease activity of EcoKI
We performed in vitro nuclease assays to analyse the level
of inhibition exerted by the mutated forms of Ocr. A
10-fold excess of Ocr was mixed with EcoKI prior to
addition to a plasmid substrate, pBRsk1, containing a
unique restriction recognition site, and the cofactors. It
has been shown previously that Ocr must be mixed with
the Type I RM enzyme prior to introducing DNA as once
ATP hydrolysis and translocation have commenced, the
Ocr can no longer bind to the translocating enzyme (12).
The mixture was then incubated at 37C for 8min before
heat quenching the reaction. Linearization of the plasmid
DNA was then assessed by subjecting the reaction mixture
to agarose gel electrophoresis (Figure 8). As can be seen, a
10-fold excess of EcoKI over DNA in the absence of Ocr
was sufﬁcient to fully digest the DNA in the time avail-
able. However, preincubation of the nuclease with a
10-fold excess of wild-type Ocr over EcoKI completely
inhibited digestion of the plasmid DNA. Similar levels of
inhibition were also observed for the Mut1, Mut2, Mut4
Ocr mutants and the two truncated versions of Ocr99 and
Ocr109. However, no observable inhibition was evident
for Mut3, Mut10, Mut11, Mut12, Mut13 and Mut16
under the same experimental conditions. Mut7 displayed
partial inhibition of DNA digestion. However, when the
experiment was conducted at a molar ratio of 1:20,
EcoKI:Mut7 the inhibition of nuclease activity was
complete (Roberts, G.A., unpublished data).
DISCUSSION
Structural implications of the mutational analysis of Ocr
Our data allow four groups of Ocr mutants to be deﬁned
(Table 4). These groups are: Ocr mutants with normal
activity indistinguishable from the wild-type Ocr;
mutants with nearly normal activity; mutants with some
activity but with further deleterious effects on cell viability
and lastly Ocr mutants with no activity. As expected from
previous chemical modiﬁcation experiments (16), the
structural fold of Ocr proved to be very robust to muta-
genesis. Introducing extensive changes to its surface with
up to 17 amino acid substitutions per monomer were
tolerated. Thus it would be reasonable to suppose that
the structure would be maintained in vivo even if the
activity of mutants had been compromised.
We ﬁnd that our mutational analysis indicates that
mimicry of the electrostatics of the bend at the centre of
the EcoKI DNA target sequence is a major contributor to
the activity of Ocr as an anti-RM protein. This comple-
ments the conclusions reached by our chemical modiﬁca-
tion study (16) where it was found that mimicry of the
bend in the DNA target was important but not sufﬁcient
to make Ocr a strong inhibitor of Type I RM enzymes. In
other words, mimicry by Ocr of the charge and the shape
of the bend in the DNA target add together.
Wild type activity is observed when the aspartate and
glutamate residues in the sequence ranges aa12–26, aa25–
35 or 92–99 (Mut1, 2 and 4) are mutated. Adding together
the mutations of Mut2 and Mut4 to create Mut7 has a
mild effect with the loss of the ability of Ocr to protect a
clp strain, in the presence of 2AP, from EcoKI.
The section of mutated amino acids, aa59–73 (Mut3 and
12), has a severe effect on activity and cell viability particu-
larly when the amino acid substitution D73C is made in
Mut3. Combining this deleterious section with aa12–26 in
Mut1 has a slight effect on binding afﬁnity in vitro in add-
ition to the effects observed withMut3 or Mut12. However
combining this deleterious section (Mut3 or Mut12) with
Mut2 orMut4 abolishesOcr activity and restores cell viabil-
ity. This section is clearly important for activity.
The effects of deleting or mutating the C-terminal tail of
Ocr are varied. Truncation of Ocr has either no effect
(Ocr99) or is unable to prevent methylation in vivo but
can prevent restriction in vivo and in vitro (Ocr109). The
inability of Ocr109 to prevent methylation in vivo is difﬁ-
cult to explain given that it can bind tightly to the EcoKI
MTase in vitro. The Ocr/POcr mutant with extensive
replacement of aspartate and glutamates from aa76
Figure 6. Far-UV CD spectra of wild-type Ocr (black) and several
variants: Mut1 (olive), Mut3 (orange), Mut7 (magenta), Mut10 (red) and
Ocr/POcr (green). The protein concentration was 30 mM in each case.
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onwards, although it can bind tightly to the Mtase, other-
wise behaves as the Mut3 and Mut12 mutants with severe
effects on cell viability. Since Ocr/POcr contains the aa
changes made to construct Mut4, which have no effect
on Ocr activity, and the tail region which can be deleted
(Ocr99 and Ocr109) with little effect, it would appear that
the section from aa76 to 91 are crucial for the effects
observed with Ocr/POcr (Ocr/POcr substitutions minus
those in Ocr99 and Mut4).
Combining this region of Ocr/POcr with the region
identiﬁed in Mut3, aa59–73, then indicates that a block
of charge found between aa59 and 91 on the surface of
Ocr is crucial for Ocr activity. The region between aa59
and 91 comprises the bend in the centre of the convex
surface of the Ocr protein (Figure 9). Recalling the bipart-
ite nature of the DNA target sequence recognized by
a Type I RM enzyme, e.g. EcoKI recognizes AACNNN
NNNGTGC and bends the non-speciﬁc spacer sequence,
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Figure 7. Isothermal titration calorimetry of the interaction between M.EcoKI and several variants of Ocr. (A) Titration of M.EcoKI with Mut4
protein showing tight binding as observed previously with wild-type Ocr (13). (B) Titration of M.EcoKI with Mut3 protein showing a sigmoidal
transition characteristic of weaker binding than wild-type Ocr. (C) Titration of M.EcoKI with Mut10 protein showing no binding interaction at all.
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Table 4. Summary of results with Y indicating yes, N indicating no and XnM indicating the dissociation constant for binding
Ocr variant
expressed
Active
versus
whole RM
system
in vivo
Active
versus
M.EcoKI
alone
in vivo
Protection
against
restriction of
chromosome
in presence
of 2AP
Normal
growth in
liquid
culture
without
IPTG
Normal
growth in
liquid
culture
+IPTG
Normal cell
morphology
Normal
growth on
solid media
without
IPTG
Binding to
M.EcoKI
in vitro
Inhibition of
nuclease
in vitro
Summary
Wild type Y Y Y Y Y Y Y Y Y Normal Ocr
Mut1 Y Y Y Y Y Y Y Y
Mut2 Y Y Y Y Y Y Y Y
Ocr99 Y Y Y Y Y Y Y Y
Mut4 Y Y Y Y Y Y Y Y
Ocr109 Y N Y Y Y Y Y Y Normal but
some odd
effects
Mut7 Y Y N Y Y Y Y Y
Ocr/pOcr Y N N Y N N N Y N Weakening
binding, some
loss of activity.
Cells sick due
to lack of RA.
Mut3 Y N N Y N N Y 79nM N
Mut12 Y N N N N N N 20nM N
Mut16 Y N N N N N N 71nM N
Mut13 N N N Y Y Y 41nM N Total loss of
activity and
cells are well.
Mut10 N N N Y Y Y N N
Mut11 N N N Y Y Y N N
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Figure 8. The effect of Ocr and variants on DNA cleavage by EcoKI. The end lanes show 1 kbp DNA size markers increasing from 2kb to 7 kb.
The pBRsk1 lanes show the uncut plasmid predominantly in the supercoiled form with a small amount of open circular form running more slowly.
The EcoKI lanes show linearization of the DNA by EcoKI. The other lanes show the effect of Ocr and its variants on EcoKI activity. The enzyme
was mixed with the Ocr proteins at a ratio of 1 enzyme per 10 Ocr prior to addition to the DNA sample.
Table 3. ITC analyses for the interaction of the M.EcoKI MTase with Ocr or its variants
Ocr variant Stoichiometry Ocr
dimers per M.EcoKI
Enthalpy (kcal mol1) Dissociation constant
(Kd) (nM)
Wild typea 0.87±0.01 20.5±0.3 Too tight
Mut1 0.98±0.01 13.8±0.3 Too tight
Mut2 1.04±0.01 14.5±0.2 Too tight
Mut3 0.93±0.02 14.7±0.5 79±21
Mut4 0.83±0.01 19.4±0.2 Too tight
Mut7 0.99±0.01 12.5±0.3 Too tight
Mut10 0 0 no binding
Mut11 0 0 no binding
Mut12 0.90±0.01 15.4±0.4 20±9
Mut13 1.18±0.03 11.0±0.4 41±16
Mut16 0.98±0.03 8.2±0.4 71±30
Ocr/POcr 0.89±0.01 15.3±0.2 Too tight
Ocr99a 0.71±0.01 22.4±0.7 Too tight
Ocr109a 0.74±0.01 25.0±0.6 Too tight
aData from (17).
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then our data indicate that the central region of Ocr
mimics the six base pairs comprising the bent non-speciﬁc
spacer. The majority of Asp and Glu residues in this
region are not making signiﬁcant contacts with the
TRDs of the S subunit as they lie in the region between
the TRDs over the helical spacer which links the TRDs.
The one exception to this is amino acid D73 which is close
to the region of the TRDs predicted to be in contact with
DNA in the M.EcoKI–DNA complex. Since the TRDs
contain a signiﬁcant number of Arg and Lys residues for
DNA recognition then the major effect of removing the
charge of D73 by substituting it with Cys can be
rationalized. Its removal would upset the electrostatics
of this Ocr–TRD interface and account for the enhanced
effect of Mut3 over Mut12, which lacks the D73C substi-
tution. The aa59–91 region extends up the face of Ocr and
would make additional contacts to the M subunit.
The other mutations outside of aa59–91 identify regions
which are not absolutely essential for activity but changes
in them enhance the deleterious effects of mutations in the
aa59–91 region. The amino acids in Mut1, Mut2, Mut4
and after aa99 in Ocr/POcr can be seen to occupy pos-
itions in the Ocr structure equivalent to the AAC and
GTGC segments of the target sequence plus non-speciﬁc
DNA sequence extending beyond the target site, Figure 9,
in agreement with regions identiﬁed previously (13). The
regions of Ocr mimicking the AAC and GTGC elements
of the target sequence do not seem to be major contribu-
tors to the effectiveness of Ocr as an inhibitor of Type I
RM enzymes. As previously noted (4,9), this would be
expected as Ocr is a non-speciﬁc inhibitor of all Type I
RM enzymes irrespective of the target sequence
recognized by the RM enzyme. The regions of Ocr
mimicking the non-speciﬁc DNA ﬂanking the target
sequence similarly appear to make minor contributions
to the effectiveness of Ocr as an inhibitor.
Effects of Ocr mutations on cell viability
The effect of these central Ocr mutants on cell viability
was unexpected as wild-type Ocr has no such effect nor do
the mutants which have completely lost anti-RM activity.
The results for the mutants affecting cell viability appear
contradictory in that the mutant Ocr proteins which retain
the ability in vivo to halt restriction of phage DNA do not
prevent restriction of unmodiﬁed host DNA induced by
the presence 2AP. In vitro, they do not halt restriction
despite the fact that they bind the MTase reasonably
well. This difference in behaviour towards unmodiﬁed
sites on phage and the chromosome has been observed
previously and attributed to the different abilities of the
Type I RM enzyme to translocate on naked phage DNA
versus DNA contained in the nucleoid (29,41). It may also
indicate that the larger RM enzyme is more excluded from
the nucleoid than the smaller MTase.
However it has also been noted that the R restriction
subunit is in short supply in vivo compared to the MTase
core in the EcoKI Type I RM system (42). Thus an excess of
MTase is usually present in vivo. Normally, wild-type Ocr
removes all of theMTase and theRMenzyme activity in the
cell thus resulting in unmodiﬁed chromosomal DNA. A
totally inactive Ocr mutant does not remove the RM
enzyme thus the chromosome remains modiﬁed by
EcoKI. However, if the Ocr activity is only partially dimin-
ished then both the MTase and the RM enzyme will be di-
minished in quantity. The MTase would be unable to
maintain chromosomal methylation thus allowing even a
single unmodiﬁed target site to stimulate cleavage of the
chromosome by even a single copy of the RM enzyme.
However the presence of minimal amounts of the RM
enzyme would appear to be insufﬁcient to give effective re-
striction of invading phage during the relatively short phage
1 AMSNMTYNNV FDHAYEMLKE NIRYDDIRDT DDLHDAIHMA
41 ADNAVPHYYA DIFSVMASEG IDLEFEDSGL MPDTKDVIRI
81 LQARIYEQLT IDLWEDAEDL LNEYLEEVEE YEEDEE
Mut2
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Figure 9. A comparison of the location of the amino acid substitutions
made in Ocr with the bent DNA target bound by M.EcoKI (DNA
coordinates from 27; pdb 2Y7H). (A) The DNA is coloured magenta
for base pairs lying outside of the target sequence, speciﬁc base pairs
recognized by M.EcoKI (AAC and GTGC) are coloured green and the
non-speciﬁc spacer of six base pairs is coloured orange. Asp and Glu
residues in Ocr equivalent to these regions in DNA are coloured in the
same way. Residue D73 found to be important in the Mut3 variant of
Ocr is highlighted. The yellow ribbon structure is the S subunit of
EcoKI bound to Ocr (27; pdb 2Y7C) showing that the TRDs regions
contact the green region in Ocr and the DNA while the alpha helical
linkers between the TRDs are close to the orange region of Ocr and the
DNA. (B) The sequence of Ocr with the residues equivalent to the
magenta, green and orange regions of the DNA in panel A coloured
similarly. The regions of the mutations are indicated.
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life cycle and thus theOcrmutant appears to be active in the
phage restriction assay. In effect, these Ocr mutations are
creating an r+/m+/ phenotype for the EcoKI RM system
depending upon the experimental conditions where concen-
trations of unmodiﬁed DNA targets sites, EcoKI RM
enzyme, M.EcoKI and Ocr are varying.
How did Ocr evolve?
Evolutionary theory predicts that improved ﬁtness of one
species will be at the expense of another species in the
same environment (the Red Queen hypothesis; 43).
Bacteriophages are a primary predator of bacteria and
the pairwise interaction of phage and host drives evolution
of new traits that protect the bacterium from predation,
while the predator evolves to overcome new defences (44).
Bacteria have evolved numerous strategies to prevent in-
fection, ranging from phase-variable surface receptors and
polysaccharides to RM, CRISPR-Cas and toxin-antitoxin
systems (45). These mechanisms have been collectively
referred to as the ‘resistome’ (46).
Following phage adsorption, the injected DNA will be
recognized as ‘foreign’ by the resident RM systems of the
infected bacterium. Phages have evolved counter-strategies,
such as inclusion of unusual bases in their DNA and
anti-RM proteins, e.g., Ocr. The amino acid composition
of Ocr is far from that expected for a soluble globular
protein with a chain length of 116 amino acids. Negative
residues are over-represented (34 instead of 12 expected),
and positive residues under-represented (6 instead of 12
expected). If one presumes that the progenitor of Ocr had
a more average amino acid composition and no anti-RM
activity thenmutations would have to accumulate to obtain
activity. The reduction in the proportion of basic residues
during the course of evolution is probably not too signiﬁ-
cant or unlikely. The acquisition of many extra acidic
residues, however, if all were required for anti-RM
activity, would seem less likely. Our mutagenesis and
chemical modiﬁcation data (16) indicate that far fewer
than 34 acidic residues are required for anti-RM activity.
Sequence alignment of Ocr homologues supports this
notion, with only 15 conserved or nearly conserved
acidic residues present over the homologous sequences
(Supplementary Figure S2). It is therefore possible that
Ocr evolved from a protein scaffold that already contained
a signiﬁcant number of acidic residues and which interacted
with another DNA binding protein. We note early work
that showed showing a strong interaction of Ocr with the
RNA polymerase of E. coli (47). Furthermore, a number of
the acidic residues in ﬁrst and fourth helices of Ocr (4)
appear to contain motifs that are present in other DNA-
mimicking proteins, e.g. DinI and UGI (3). DinI mimics
single-stranded DNA and interacts with RecA during
SOS induction in E. coli (48). It is possible that T7
acquired a gene encoding aDinI-like homologuewhich sub-
sequently evolved a minimal anti-RM activity and
continued to rapidly mutate, under coevolutionary
pressure, to acquire greater anti-RM activity. We note
that genes encoding DinI homologues are present in some
phage genomes, e.g. the cytotoxin converting phage
CDT-1f (49).
The switch from original function to anti-RM would
appear, from our data, to require only a few amino acid
changes. Thus, a minimal DNA mimic anti-RM protein
should arise easily. Although it also creates a problem for
cell viability this should not be a signiﬁcant problem for a
lytic phage such as T7. Selection for reduced toxicity,
better DNA mimicry and improved anti-RM function
can occur subsequently to improve the binding afﬁnity
of the anti-RM protein for the Type I RM enzyme to
such a degree that the RM enzyme:anti-RM complex
becomes more stable than the RM enzyme:DNA
complex: the situation now observed for the interaction
of Ocr with Type I RM enzymes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Table 1 and Supplementary Figures
1 and 2.
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